Envigo appoints Lynn Lewis as Senior Vice President of Global Sales 27th February 2018
Envigo, a leading provider of nonclinical contract research services and research models, have announced the appointment of Lynn Lewis to the position of Senior Vice President, Global Sales. She brings extensive knowledge in both science and business to the company through her successful career in pharmaceuticals and leadership roles within sales and operations in the contract research organization (CRO) industry. This new role was created to strengthen the company’s position in the marketplace with a focus on continuing to provide outstanding customer service. Lynn will report to Craig Boyd, Envigo’s Chief Commercial Officer.
“Given the dynamic growth in the CRO industry, there is an increasing opportunity to further engage our existing customers, as well as attract emerging life sciences companies to Envigo’s extensive non-clinical service offerings and research products. We are thrilled that Lynn Lewis has joined our team to drive this important effort,” said Dr. Adrian Hardy, President and Chief Executive Officer. “Lynn’s broad experience leading billion dollar, successful global sales organizations serving the biopharmaceutical industry will be an invaluable asset to our commercial team. Under her guidance, our sales teams in North America, Europe and Asia Pacific will be unified which will provide additional focus on enterprise-wide growth initiatives and an enhanced customer experience, while contributing to our vision to work together to build a healthier and safer world.”
Prior to joining Envigo, Lynn was most recently Group Vice President of Business Development, Clinical Development and Commercialization Services for Covance. During her 15 year career with Covance, she also led the global sales organizations for Covance’s nonclinical and central laboratory businesses and also served as the General Manager of Covance’s drug discovery and development campus in Greenfield, Indiana. Before joining Covance, Lynn worked for Eli Lilly and Company leading cross functional development teams to bring new medicines to market. She holds a Master of Business Administration from University of North Carolina at Chapel Hill and a Bachelor of Science degree in Biology from Bucknell University.